RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
RF
+
Structure of a camel nanobody illustration Nanobodies are also known as single domain antibodies They are small in size with novel therapeutic cha
RF
+
Illustration of a bispecific antibody showing two discrete antigen binding sites (pink and green) within the antibody structure by THOM LEACH SCIE
RF
+
Illustration of a bispecific antibody (yellow and orange) binding to two different membrane proteins (purple and blue) by THOM LEACH SCIENCE PHOTO
RF
+
Illustration of a bispecific antibody (pink and green) binding to two different membrane proteins (yellow and blue) by THOM LEACH SCIENCE PHOTO LI
RF
+
Illustration of a bispecific antibody (green and light blue) binding to two different membrane proteins (pink and dark blue) by THOM LEACH SCIENCE
RF
+
Illustration of a bispecific antibody (blue and purple) binding to two different membrane proteins (green and orange) by THOM LEACH SCIENCE PHOTO
RF
+
Illustration of a bispecific antibody showing two discrete antigen binding sites (pink and green) within the antibody structure by THOM LEACH SCI
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (blue) and a cytotoxic payload (orange) for ta
ED
+
Tasuku Honjo (center) a special professor at Kyoto University and others head to the Osaka District Court to appear for oral arguments in a lawsuit
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (orange)
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (glowing
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (orange)
RF
+
Illustration of a human IgG1 (immunoglobulin G1) antibody Colours represent the two light chains (green and yellow) and two heavy chains (blue and pu
RF
+
Illustration of a human IgG1 (immunoglobulin G1) antibody Colours represent the two light chains (red and purple) and two heavy chains (cyan and gree
RF
+
Illustration of a human IgG1 (immunoglobulin G1) antibody Colours represent the two light chains (blue and cyan) and two heavy chains (purple and yel
RF
+
Illustration of the ribbon protein structure of a human immunoglobulin G1 (IgG1) antibody Colours represent the two light chains (yellow and red) and
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of the antigen binding site (orange) of a human IgG1 (immunoglobulin G1) antibody by THOM LEACH SCIENCE PHOTO LIBRARY
ED
+
Tasuku Honjo (center) a special professor at Kyoto University and others head to the Osaka District Court to appear for oral arguments in a lawsuit
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibody technologies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibody technologies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
Illustration of antibodies based on the 3D structure of human immunoglobulin G1 (IGG1) by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
How to use sublingual immunotherapy as a treatment for hay fever and dust mite allergies
RF
+
How sublingual immunotherapy prevents hay fever and allergies by placing medication on the tongue
RM
+
Illustration of CAR (chimeric antigen receptor) T cell immunotherapy a process that is being developed to treat cancer T cells (shown in cross-secti
RM
+
Illustration of CAR (chimeric antigen receptor) T cell immunotherapy a process that is being developed to treat cancer T cells (shown in cross-secti
ED
+
Tasuku Honjo special professor at Kyoto University heads to the Osaka District Court to appear for oral arguments in a lawsuit over patent royalties
RM
+
Illustration of CAR (chimeric antigen receptor) T cell immunotherapy a process that is being developed to treat cancer T cells (shown in cross-secti
RM
+
Illustration of CAR (chimeric antigen receptor) T cell immunotherapy a process that is being developed to treat cancer T cells (shown in cross-secti
RF
+
Immunotherapy This is a treatment that involves using the bodys own immune system to fight cancer or other diseases by WLADIMIR BULGARSCIENCE PHO
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
ED
+
Tasuku Honjo a special professor at Kyoto University and winner of last years Nobel Prize in Physiology or Medicine announced at a press conference
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
RF
+
CAR-T cell therapy illustration
RF
+
CAR-T cell therapy illustration
ED
+
Chronic lymphoid leukaemia (CLL) Light micrograph of a section through bone marrow in a case of CLL An abnormal number of lymphocytes (purple a typ
RF
+
CAR-T cell therapy illustration
RM
+
Viruses attacking cancer cell illustration
RM
+
Viruses attacking cancer cell illustration
RM
+
Illustration of the Japanese physician and immunologist Tasuku Honjo (born 1942) In the early 1980s Honjo discovered the mechanism (class switch reco
RM
+
Illustration of the US immunologist James P Allison (born 1948) Allison is best known for his work on T cells (a white blood cell of the immune syst
RM
+
Lung cancer cells SEM
RM
+
Lung cancer cells SEM
RM
+
Lung cancer cells SEM
RM
+
Lung cancer cells SEM
ED
+
Immunotherapy in cancer treatment use of a syringe to remove purified lymphocytes from a blood bag prior to doping with Interleukin-2 (IL- 2) IL-2
RM
+
Lung cancer cell SEM
RM
+
Lung cancer cell SEM
RM
+
Lung cancer cell SEM
RM
+
Lung cancer cell SEM
RM
+
Cell therapy conceptual illustration Therapeutic cells being delivered to a tumour via its blood supply by GREGOIRE CIRADESCIENCE PHOTO LIBRARY
RM
+
Thigh bone in Erdheim-Chester disease X-ray
RM
+
Thigh bone in Erdheim-Chester disease X-ray
RM
+
Thigh bone in Erdheim-Chester disease X-ray
RM
+
T cells in a squamous cell carcinoma immunofluorescence micrograph
ED
+
Skin cancer Gross specimen of a malignant melanoma (dark area) a type of skin cancer This cancer arises from the skins melanocytes the cells that
RM
+
Aorta in Erdheim-Chester disease CT scan
RM
+
Aorta in Erdheim-Chester disease CT scan
RM
+
Conceptual illustration showing a boy playing with various coloured blocks showing different common allergens The colours correlate to those within h
RM
+
Conceptual illustration showing a factory within a man head that is producing antibodies by SAM FALCONER DEBUT ARTSCIENCE PHOTO LIBRARY
RM
+
Conceptual illustration showing a female profile facing various common allergens by SAM FALCONER DEBUT ARTSCIENCE PHOTO LIBRARY
RF
+
Illustration of T-cells attacking a cancer cell by ARTUR PLAWGO SCIENCE PHOTO LIBRARY
RF
+
Illustration of a monoclonal antibody (light blue) bound to an amyloid beta peptide (orange) Misfolded amyloid beta peptides aggregate and form amylo
RF
+
Illustration of a monoclonal antibody (blue) bound to an amyloid beta peptide (orange) Misfolded amyloid beta peptides aggregate and form amyloid pla
RF
+
Illustration of a monoclonal antibody (blue) bound to an amyloid beta peptide (orange) Misfolded amyloid beta peptides aggregate and form amyloid pla
ED
+
Immunotherapy for cancer scientist examining wells containing cell cultures of lymphocytes that have been doped with Interleukin-2 (IL-2) for possibl
RF
+
Illustration of T cells (blue) attacking cancer cells (red) CAR-T therapy is a type of immunotherapy that genetically modifies a patients own T cell
RF
+
Illustration of T cells (brown) attacking cancer cells (blue) CAR-T therapy is a type of immunotherapy that genetically modifies a patients own T ce
RF
+
Illustration of T cells (purple) attacking cancer cells (green) CAR-T therapy is a type of immunotherapy that genetically modifies a patients own T
RF
+
Illustration of a T cell (blue) attacking cancer cells (red) CAR-T therapy is a type of immunotherapy that genetically modifies a patients own T cel
RF
+
Illustration of a T cell (blue) attacking cancer cells (brown) CAR-T therapy is a type of immunotherapy that genetically modifies a patients own T c
RF
+
Illustration of a T cell (brown) attacking cancer cells (purple) CAR-T therapy is a type of immunotherapy that genetically modifies a patients own T
RM
+
Lung cancer cell SEM
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
ED
+
Immunotherapy for cancer scientist examining wells containing cell cultures of lymphocytes that have been doped with Interleukin-2 (IL-2) for possibl
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cells dividing SEM
RM
+
Lung cancer cell SEM
RF
+
Mesothelin protein bound to antibody illustration
RF
+
Protein illustration
RF
+
Illustration of mesothelin (dark blue and orange) bound to a monoclonal antibody (light blue) Mesothelin (MSLN) is a membrane glycoprotein found on m
RM
+
T cell immune checkpoint inhibition illustration
RM
+
Illustration of a T cell (bottom) binding to a tumour cell (top) Antibodies (y-shaped) are attacking an immune checkpoint between the cells T lympho
ED
+
Immunotherapy for cancer an autmomated machine adds nutrient medium to cell culture wells containing lymphocytes that have been doped with Interleuki
492
0
https://www.afloimages.com/search/immunotherapy.html